Skip to main content

Maybank Keeps Their Hold Rating on Steris (STE)

Tipranks - Sat Jan 17, 6:24AM CST

Maybank analyst Krishna Guha maintained a Hold rating on Steris on January 12. The company’s shares closed yesterday at $260.77.

Claim 70% Off TipRanks Premium

According to TipRanks, Guha is ranked #3902 out of 11984 analysts.

Steris has an analyst consensus of Hold.

Based on Steris’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.46 billion and a net profit of $191.9 million. In comparison, last year the company earned a revenue of $1.33 billion and had a net profit of $150.03 million

Based on the recent corporate insider activity of 53 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of STE in relation to earlier this year. Most recently, in November 2025, Julia Madsen, the Sr. VP and GM, Life Sciences of STE sold 5,008.00 shares for a total of $1,312,096.00.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.